Skip to content
Search

Latest Stories

NHS England mandates usage of IT system in pharmacies for Hypertension case-finding service from September

The pharmacy owners will have to use an NHS approved clinical IT system to make their clinical records and payment claims for the Hypertension case-finding service from 1st September 2023, announced NHS England.

HxConsult (Positive Solutions); Pharmacy Manager (Cegedim); PharmOutcomes (Pinnacle Health); and Sonar health (Sonar informatics) are expected to develop their systems to include functionality to support the service, but over time, it is hoped other suppliers will add the service to their systems.


Pharmacy owners providing the service will need to consider which system they want to use and will then need to enter into a contract with that supplier.

All service provisions within June, July and August 2023 should be claimed by the current manual MYS process by Tuesday 5th September. Claims at a later date will only be possible via one of the approved IT systems.

The Community Pharmacy England said: "When the Hypertension case-finding service was first launched in October 2021, the ambition was to develop IT systems that would support provision of the service.

"These IT systems will allow pharmacy teams to make a clinical record for the service and the data in the record will then be used by the IT system to populate a claim for payment within the NHSBSA’s Manage Your Service (MYS) platform.

This means pharmacy owners will not need to manually transcribe data from their records into MYS, as is currently the case. The new approach mirrors what already happens for the Community Pharmacist Consultation Service and the Flu vaccination service."

The transfer of data to the MYS platform will be via an API (Application Programming Interface) to automate payment claims and reporting of the data to the NHSBSA.

It added: "The IT systems, including the APIs, must meet minimum requirements specified within NHS IT technical toolkits. In previous negotiations with the Department of Health and Social Care and NHS England, it was agreed that once such IT systems are available, pharmacy owners must use one of these systems by an agreed deadline (in this case, 1st September 2023).

All payment claims for the service from 1st September will need to be made via the API and there will be no manual option to claim for service provisions.

The transfer of data via the API will happen throughout the month, as data is entered into the IT systems. The service provisions will then be available to view in MYS from the 1st of the following month. For example, service provisions in September will be available to view in MYS on 1st October. Contractors will then need to log into the MYS platform to check that the data matches the details in their IT system, and they will then need to submit their claim for payment."

The NHSBSA have also recently engaged with IT supplier market on the development of an API to support the Discharge Medicines Service. As this is an Essential service that pharmacy contractors must provide, they have undertaken additional engagement with the wider IT system supplier market and they will confirm timescales for the implementation in due course.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less